Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the response rate and toxicity of the
association R-CHOP with two schedules of administration of Velcade, in B-cell CD 20 +
lymphoma patients, aged from 18 to 80 years
The goal is to get a response rate at least at what observed with R-CHOP alone and will be
evaluates with a sequential test.
The other objective is to evaluate the toxicity